AI in Computer-Aided Synthesis Planning Market Report 2026

The artificial intelligence in the computer-aided synthesis planning market size has grown exponentially in recent years. It will grow from $3.35 billion in 2025 to $4.81 billion in 2026 at a compound annual growth rate (CAGR) of 43.8%. The growth in the historic period can be attributed to growing adoption of computational chemistry tools, increasing demand for automation in drug discovery, rising use of machine learning for reaction prediction, expansion of digitalization in pharmaceutical R&D, and growing need for faster synthesis route identification.

The artificial intelligence in the computer-aided synthesis planning market size is expected to see exponential growth in the next few years. It will grow to $20.43 billion in 2030 at a compound annual growth rate (CAGR) of 43.5%. The growth in the forecast period can be attributed to increasing investment in AI-driven molecular design, rising adoption of automated synthesis platforms, growing demand for high-throughput reaction optimization, expansion of partnerships between AI firms and pharma companies, and a rise in the implementation of cloud-based synthesis planning tools. Major trends in the forecast period include technology-driven algorithmic innovations, advancements in deep learning for reaction prediction, developments in autonomous laboratory systems, rising research and development in generative chemistry models, and innovation in integrated AI-enabled synthesis workflows.

The increasing adoption of AI-powered decision-making tools is expected to drive the growth of the artificial intelligence (AI) in computer-aided synthesis planning market in the coming years. AI-powered decision-making tools are software systems that leverage artificial intelligence, including machine learning and predictive analytics, to automate and enhance business decisions and insights. This adoption is driven by growing enterprise digitalization and the demand for data-driven strategic decision-making. AI in computer-aided synthesis planning supports these tools by enabling automated route design, predictive analysis, and optimization of chemical processes, thereby improving accuracy, efficiency, and strategic planning in research and development. For example, in January 2025, Eurostat, the Luxembourg-based statistical office of the European Union, reported that in 2024, 13.5% of enterprises with 10 or more employees used AI technologies, up from 8% in 2023, reflecting a 5.5 percentage-point increase. Hence, the rising adoption of AI-powered decision-making tools is fueling the growth of the AI in computer-aided synthesis planning market.

Major companies in the artificial intelligence (AI) in computer-aided synthesis planning market are focusing on developing advanced solutions, such as integrated AI platforms, to enhance efficiency, improve decision-making, and reduce the time and cost of drug development. Integrated AI solutions are software systems that leverage artificial intelligence to connect the initial design of a drug molecule with its practical, real-world manufacturability. For example, in December 2023, Merck KGaA, a Germany-based science and technology company, launched AIDDISON, a software-as-a-service platform that combines generative AI, machine-learning-based drug design, and its Synthia retrosynthesis API into a unified system. The platform can virtually screen over 60 billion chemical possibilities, assess compounds for drug-like properties, and generate optimized synthetic pathways, recommending reagents, building blocks, and route efficiencies to support practical and cost-effective drug development.

In August 2023, CAS, a division of the American Chemical Society, a US-based non-profit organization, partnered with Molecule.one. The collaboration aims to utilize Molecule.one’s AI-driven synthesis planning platform to enhance CAS’s chemical data and research capabilities, enabling faster and more efficient discovery of novel compounds and accelerating innovation in chemical research. Molecule.one is a Poland-based technology company offering AI-driven solutions for computer-aided synthesis planning (CASP) in chemical research.

Major companies operating in the artificial intelligence (AI) in computer-aided synthesis planning market are International Business Machines Corporation, Elsevier B.V., Schrödinger Inc., Insilico Medicine Inc., ChemAxon Ltd., ASKCOS, Iktos SAS, Enamine Ltd., Chemical AI, PostEra Inc., Molecule One Sp. z o.o., BioSolveIT GmbH, Chemify Ltd., Xemistry GmbH, Scilligence Corporation, Citrine Informatics Inc., Chemopilot, DeepMatter Group plc, SynthIA, AiZynthFinder.

North America was the largest region in the artificial intelligence in computer aided synthesis planning market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial intelligence (AI) in computer-aided synthesis planning market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the artificial intelligence (AI) in computer-aided synthesis planning market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Tariffs have had a moderate impact on the artificial intelligence in computer aided synthesis planning market by increasing costs for imported high performance computing hardware, servers, and specialized laboratory automation equipment used in on premises deployments. Hardware dependent research institutions and pharmaceutical companies in north america and europe are more affected, while asia pacific remains a major supplier of computing components. These tariffs have increased upfront infrastructure costs and slowed some on site implementations. However, they have also encouraged greater adoption of cloud based synthesis planning platforms, software centric delivery models, and regional data hosting, supporting broader market accessibility and scalability.

Artificial intelligence (AI) in computer-aided synthesis planning refers to the application of advanced machine learning models and algorithmic systems to design, optimize, and predict efficient chemical synthesis routes for both new and existing molecules. Its primary aim is to accelerate chemical discovery, minimize trial-and-error experimentation, and improve the accuracy and feasibility of synthesizing complex compounds. It also facilitates faster workflow automation, enhanced decision-making in research laboratories, and increased innovation in chemical, pharmaceutical, and materials development.

The main offerings in AI for computer-aided synthesis planning include software platforms and services. Software platforms are widely used, employing machine learning and deep learning algorithms to predict reaction pathways, optimize synthesis routes, and reduce time and cost in complex chemical synthesis planning. These solutions utilize technologies such as machine learning, deep learning, natural language processing, and others, and are deployed through both cloud-based and on-premises models. AI in computer-aided synthesis planning finds applications across drug discovery and medicinal chemistry, materials science, agrochemicals, academic research, and more, serving end-users such as pharmaceutical and biotechnology companies, chemical manufacturing and materials science organizations, contract research organizations, and academic and research institutions.

The artificial intelligence (AI) in computer-aided synthesis planning market consists of revenues earned by entities through the provision of services such as retrosynthetic route planning and optimization, predictive reaction outcome modeling, automated molecule design and lead optimization, data curation and reaction-annotation services, and implementation and integration consulting for laboratory informatics and workflow automation. The market value includes the value of related goods sold by the service provider or included within the service offering. The artificial intelligence (AI) in computer-aided synthesis planning market also includes sales of synthesis planning software platforms, reaction-prediction engines, cheminformatics and molecular-design toolkits, curated reaction and reagent databases, and laboratory workflow automation connectors and integration modules. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.